is semaglutide still in short supply shortage ends as FDA sets deadline for compounders Weight-loss jab could be made

Annals of Hepatology

They talk about this a bit, but make the (odd, to me, at least) choice to compare the 104-week SELECT (cardiovascular) trial to the 68-week STEP 1 (weight loss) trial, rather than the 104-week STEP 5 (weight loss) Trial

Effect of retatrutide on kidney parameters in people with type 2 diabetes and/or obesitya post-hoc analysis of two phase 2 trials

Tirzepatide may be a suitable option for individuals struggling with obesity , overweight conditions, or Type 2 diabetes

or overweight if their BMI is greater than 27 accompanied by weight-related medical problems such as high blood pressure, type 2 diabetes, or high cholesterol

Medical review by licensed providers Medication + supplies included No clinic visits required Injections and oral options available Check if you qualify No Hidden Fees | Secure & Private | US Licensed Pharmacies Personalized Prescription How it works From Online Assessment to Treatment at Home Your care is handled by licensed medical providers through a streamlined telehealth process designed for safety, privacy, and convenience